Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Tvardi Therapeutics, Inc. (TVRD) had Earnings per Share (EPS) (Basic) of $0.84 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-11.95M |
|
-- |
|
-- |
|
$6.99M |
|
$-6.99M |
|
$-2.39M |
|
$-11.95M |
|
$-11.95M |
|
$-11.95M |
|
$-11.95M |
|
$-11.95M |
|
$-11.95M |
|
$-9.55M |
|
$-7.16M |
|
7.42M |
|
7.78M |
|
|
Earnings per Share (EPS) (Basic) |
$0.84 |
$1.55 |
|
| Balance Sheet Financials | |
$31.54M |
|
$0.05M |
|
$0.54M |
|
$32.07M |
|
$11.04M |
|
-- |
|
$0.09M |
|
$11.13M |
|
$20.95M |
|
$20.62M |
|
$20.95M |
|
9.38M |
|
| Cash Flow Statement Financials | |
$-23.50M |
|
$-10.08M |
|
$22.70M |
|
$31.61M |
|
$20.73M |
|
$-10.88M |
|
$1.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.86 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.50M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-57.04% |
|
-57.93% |
|
-37.25% |
|
-57.04% |
|
$2.23 |
|
$-3.02 |
|
$-3.02 |
|